Effect of acute and chronic inhaled furosemide on bronchial hyperresponsiveness in mild asthma. 1995

D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
Department of Thoracic Medicine, National Heart and Lung Institute, Royal Brompton Hospital, London, UK.

We determined whether chronic administration of furosemide aerosol would be beneficial for the treatment of asthma. First, we showed that furosemide aerosol delivered from a metered-dose inhaler (10 and 20 mg) significantly protected against sodium metabisulfite (MBS) challenge by 0.6 and 1.3 doubling dilutions respectively in 12 volunteers with mild asthma. In a double-blind cross-over study, we examined the effect of furosemide aerosol from a twice more efficient metered-dose inhaler (10 mg four times per day) inhaled over 4 wk versus placebo in 12 other asthmatic subjects. There was no significant effect of furosemide on bronchial responsiveness to methacholine or MBS. Treatment with furosemide over 1 mo did not improve bronchial hyperresponsiveness in subjects with mild asthma.

UI MeSH Term Description Entries
D008297 Male Males
D009330 Nebulizers and Vaporizers Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. Atomizers,Inhalation Devices,Inhalators,Inhalers,Vaporizers,Nebulizers,Vaporizers and Nebulizers,Atomizer,Device, Inhalation,Devices, Inhalation,Inhalation Device,Inhalator,Inhaler,Nebulizer,Vaporizer
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
December 1995, Asian Pacific journal of allergy and immunology,
D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
January 1998, The Journal of asthma : official journal of the Association for the Care of Asthma,
D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
March 2003, Chest,
D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
July 1992, Nihon Kyobu Shikkan Gakkai zasshi,
D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
September 1995, British journal of clinical practice. Supplement,
D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
March 1993, The European respiratory journal,
D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
May 1994, Nihon Kyobu Shikkan Gakkai zasshi,
D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
October 2001, Chest,
D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
April 2015, Indian journal of pediatrics,
D H Yates, and B J O'Connor, and G Yilmaz, and S Aikman, and M Worsdell, and P J Barnes, and K F Chung
January 1998, Journal of investigational allergology & clinical immunology,
Copied contents to your clipboard!